Kraig Biocraft Laboratories, Inc logo

Kraig Biocraft Laboratories, Inc

KBLB
Last price US$0.0871
Market cap US$114.3m
12M price change -3.22%
Loading the 12-month Mave Thesis and 1-month news signal

Dashboard Funda..tals Prediction Screener Map

Kraig Biocraft Laboratories, Inc Overview

Industry: Specialty Chemicals

Sector: Basic Materials

Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. The company's products are used in military and police, and defense applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aero-space industry. Its products are also used in various markets, such as medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles, as well as textiles used in buildings and transportation. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan. Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of Read More

Mavefund brings filings, fundamentals, valuation, price history and news for Kraig Biocraft Laboratories, Inc into one research view. The sections below show what strengthens or weakens the research case.

Score

Reported Results

What the company reported, with filing details kept small.

Filed May 14, 2026

Quarterly result summary

Latest company-filed earnings material is available for source review.

What changed

  • Review the SEC source filing for the full reported results and management commentary.

Guidance / outlook

No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

SEC filing Open filing

Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

Other recent earnings materials

Prediction-grade evidence

Recent News

Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

Earnings Per Share

Score 1.00/5
Kraig Biocraft Laboratories, Inc earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Linde PLC NEWMARKET CORP Sherwin-Williams Co
In Specialty Chemicals industry , Linde PLC , NEWMARKET CORP , Sherwin-Williams Co are companies with high ratings.

Return on Equity

Score 1.79/5
Kraig Biocraft Laboratories, Inc exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Linde PLC NEWMARKET CORP Sherwin-Williams Co
Kraig Biocra... KBLB US$114.3m
Linde PLC LIN US$246.2b
NEWMARKET CO... NEU US$7.0b
Sherwin-Will... SHW US$82.8b

Net Margin

Score 2.36/5
Kraig Biocraft Laboratories, Inc olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Linde PLC NEWMARKET CORP Sherwin-Williams Co
Kraig Biocra... KBLB US$114.3m
Linde PLC LIN US$246.2b
NEWMARKET CO... NEU US$7.0b
Sherwin-Will... SHW US$82.8b

Share Buyback

In Specialty Chemicals industry , Linde PLC , NEWMARKET CORP , Sherwin-Williams Co are companies with high ratings.

Leverage

Score 3.00/5
Kraig Biocraft Laboratories, Inc attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Linde PLC NEWMARKET CORP Sherwin-Williams Co , also exhibit high scores.
Kraig Biocra... KBLB US$114.3m
Linde PLC LIN US$246.2b
NEWMARKET CO... NEU US$7.0b
Sherwin-Will... SHW US$82.8b

Financial Statements

Company-reported SEC EDGAR facts organized into the three core statements.

Verified SEC statements load when this section enters view.

Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

Financial Ratio

Yearly Quarterly

Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios

Kraig Biocraft Laboratories, Inc logo

Kraig Biocraft Laboratories, Inc

US$0.0871

US$114.3m

-11.84%

-3.22%